title: Magnesium in chronic kidney disease: challenges and opportunities.
abstract: Cardiovascular disease is the leading cause of mortality and morbidity in patients with chronic kidney disease, which is partly explained by the fact that 40-70% of patients receiving dialysis have significant coronary artery disease. Recent clinical studies have shown that lower serum magnesium (Mg) levels are associated with vascular calcification and cardiovascular mortality among patients with end-stage renal disease (ESRD). On the other hand, hypermagnesemia inhibits parathyroid hormone secretion, which is considered an important independent risk factor for vascular calcification, left ventricular hypertrophy and mortality in ESRD patients. Finally, increasing evidence points towards a link between Mg and cardiovascular disease, even in subjects without chronic kidney disease. The purpose of this review was to critically review the current literature examining the effects of plasma Mg levels on cardiovascular disease and parathyroid hormone homeostasis in ESRD, and renal transplant patients.
authors.affiliation: Department of Internal Medicine, Section of Nephrology, Fatih University School of Medicine, Ankara, Turkey. drkanbay@yahoo.com
authors.forename: Mehmet
authors.initials: M
authors.lastname: Kanbay
authors.forename: David
authors.initials: D
authors.lastname: Goldsmith
authors.forename: Mehtap Erkmen
authors.initials: ME
authors.lastname: Uyar
authors.forename: Faruk
authors.initials: F
authors.lastname: Turgut
authors.forename: Adrian
authors.initials: A
authors.lastname: Covic
mesh_terms: D001161:Arteriosclerosis / Q000209:etiology; D050197:Atherosclerosis / Q000209:etiology; D002114:Calcinosis / Q000209:etiology; D002318:Cardiovascular Diseases / Q000209:etiology; D002339:Carotid Arteries / Q000473:pathology; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000188:drug therapy / Q000401:mortality; D016030:Kidney Transplantation / Q000009:adverse effects; D008274:Magnesium / Q000097:blood*; D010281:Parathyroid Hormone / Q000037:antagonists & inhibitors / Q000097:blood; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects; D006435:Renal Dialysis / Q000009:adverse effects; D051436:Renal Insufficiency, Chronic / Q000097:blood* / Q000150:complications; D017539:Tunica Intima / Q000473:pathology; D017540:Tunica Media / Q000473:pathology
chemical_list: D010281:Parathyroid Hormone; D008274:Magnesium